期刊文献+

尾加压素Ⅱ致体外培养乳鼠心肌细胞肥大效应研究 被引量:4

Effect of urotensin Ⅱ on hypertrophy of cardiac myocytes from neonatal SD rats
原文传递
导出
摘要 目的观察尾加压素Ⅱ(Urotensin Ⅱ,U Ⅱ)对心肌细胞肥大的效应。方法以体外培养的SD乳鼠心肌细胞为实验模型,分为正常对照组,单纯UⅡ作用组,环胞素A(CsA)阻断组。用real-time PCR方法分析β-MHC、CaN(钙调神经磷酸酶) mRNA表达的变化,用免疫印迹法(Western blot)研究心肌肥大过程中β-MHC、CaN蛋白表达的变化,探讨UⅡ对心肌细胞肥大的影响。结果①随着UⅡ浓度的增加,心肌细胞β-MHC、CaN mRNA和蛋白表达明显增加,其中10-8、10-7mol/L U Ⅱ组与对照组相比较差异显著(P<0.05);②用10-8mol/L U Ⅱ处理心肌细胞12、24、48 h,随着时间增加,心肌细胞β-MHC、CaN mRNA和蛋白表达呈递增趋势,其中处理24h组与正常对照组有显著差异(P<0.05);③预先用环胞素A5μmol/L(cyclosporin A CsA)处理正常心肌细胞24 h,然后用10-8mol/L U Ⅱ作用24 h,心肌细胞β-MHC、CaN mRNA和蛋白表达与正常心肌细胞经10-8mol/L U Ⅱ单纯作用24 h差异有显著意义(P<0.05)。结论 U Ⅱ能够诱导心肌细胞的肥大,环胞素A(CsA)能阻断此效应,CaN参与了UⅡ诱导的心肌肥大过程。 Objective To explore the mechanism by which urotensin Ⅱ induces hypertrophy of the cultured rat cardiomyocytes. Methods The cultured cardiomyocytes from neonatal SD rats were treated with urotensin Ⅱ , also with cyclosporine A for its blocking effect on urotensin Ⅱ induced cardiomyocytes hypertrophy. The mRNA and protein levels of ^-MHC and CaN were evaluated by real-time PCR and Western blotting, respectively. Results In the cells treated with 10^-8 and 10^-7mol/L urotensin Ⅱ, the mRNA and protein levels of β-MHC and CaN were significantly higher than that of control (P 〈 0.05 ). Treatment of cardiomyocytes with 10^-8 mol/L urotensin Ⅱ for 12 -48 h induced a time-dependent increase of β-MHC and CaN mRNA and protein expressions (P 〈 0.05). Urotensin Ⅱ -induced upregulation of β-MHC and CaN mRNA and protein expressions can be abated by 24-hour cyclosporine A pretreatment (P 〈0.05). Conclusion Urotensin Ⅱ can induce cardiomyocytes hypertrophy and eyclosporine A can block this effect. CaN participates in this process. Our results may contribute to the investigation of cardiaomyocyts hypertrophy induced by hypertension and other cardiac diseases.
出处 《第三军医大学学报》 CAS CSCD 北大核心 2008年第24期2293-2295,共3页 Journal of Third Military Medical University
基金 重庆市自然科学基金(2007BB5026)~~
关键词 尾加压素Ⅱ 心肌细胞 肥大 钙调神经磷酸酶 urotensin Ⅱ cardiac myocyte hypertrophy calcineurin
  • 相关文献

参考文献3

二级参考文献36

  • 1张家明,李大强,于世龙,冯义柏,胡还忠.坎地沙坦对家兔快速心房刺激所致缝隙连接蛋白40重构的影响[J].中国心脏起搏与心电生理杂志,2005,19(5):385-387. 被引量:13
  • 2Coulouarn Y, Lihrmann I, Jegou S, Anouar Y, Tostivint H,Beauvillain JC, et al. Cloning of the cDNA encoding the urotensinⅡ precursor in frog and human reveals intense expression of the urotensin Ⅱ gene in motoneurons of the spinal cord. Proc Natl Acad Sci USA 1998; 95: 15803-8.
  • 3Ames RS, Sarau HM, Chambers JK, Willette RN, Aiyar NV,Romanic AM, et al. Human urotensin-Ⅱ is a potent vasoconstrictor and agonist for the orphan receptor GPRI4. Nature 1999, 401: 282-6.
  • 4Douglas SA, Tayara L, Ohlstein EH, Halawa N, Giaid A. Congestive heart failure and expression of myocardial urotensin Ⅱ. Lancet 2002; 359: 1990-7.
  • 5Johns DG, Ao Z, Naselsky D, Herold CL, Maniscalco K, Sarov-Blat L, et al. Urotensin-Ⅱ-mediated cardiomyocyte hypertrophy:effect of receptor antagonism and role of inflammatory mediators.Naunyn Schmiedebergs Arch Pharmacol 2004; 370: 238-50.
  • 6Egginger JG, Camus A, Calas A. Urotensin-Ⅱ expression in the mouse spinal cord. J Chem Neuroanat 2006; 31: 146-54.
  • 7Zhang YG, Qi YF, Xia CF, Pang YZ, Yang J, Zhang ZK, et al.Stimulating proliferation of aorta smooth muscle cells of rat byurotensin Ⅱ. Chin Pharmacol Bull 2001; 17: 155-7.
  • 8Shi L, Ding W, Li D, Wang Z, Jiang H, Zhang J, et al. Proliferation and anti-apoptotic effects of human urotensin Ⅱon human endothelial cells. Atherosclerosis 2006; 188: 260-4.
  • 9Watanabe T, Suguro T, Kanome T, Sakamoto Y, Kodate S,Hagiwara T, et al. Human urotensin II accelerates foam cell formation in human monocyte-derived macrophages. Hypertension 2005; 46: 738-44.
  • 10Russell FD, Molenaar P. Investigation of signaling pathways that mediate the inotropic effect of urotensin-Ⅱ in human heart. Cardiovasc Res 2004; 63:673-81.

共引文献48

同被引文献31

  • 1郭勇,张西正,魏严,张永红,李瑞欣.新生大鼠心肌细胞的体外培养和生物学观察[J].生物医学工程研究,2006,25(4):259-262. 被引量:6
  • 2叶盈,黄飞翔,陈美华,严萍,林求诚,王永,吴耀中,陈炳旺.健心颗粒治疗慢性心力衰竭65例临床观察[J].中医杂志,2006,47(1):28-30. 被引量:23
  • 3李明子,裴海成.尾加压素Ⅱ及受体拮抗剂与糖尿病及肾脏病[J].第二军医大学学报,2007,28(7):756-757. 被引量:4
  • 4Bianca B, Harm K, Robert H. Calpain inhibition prevents pacinginduced cellular remodeling in a HL-1 myocyte model for atrial fibrillation [J]. Cardiovasc Res, 2004, 62(3): 521-528.
  • 5Benardeau A, Hatem S N, Rucker-Martin C, et al. Primary culture of human atrial myocytes is associated with the appearance of structural and functional Characteristics of Immature Myocardium [J]. J Mol Cell Cardiol, 1997, 29(5) : 1307-1320.
  • 6Hinton M, Mellow L, Halayko A J, et al. Hypoxia induces hypersensitivity and hyperreactivity to thromboxane receptor agonist in neonatal pulmonary arterial myocytes [J ]. Am J Physiol Lung Cell Mol Physiol, 2006, 290(2) : L375-384.
  • 7Hsua K L, Fanb H J, Chen Y C, et al. Protein kinase C-Fyn kinase cascade mediates the oleic acid-induced disassembly of neonatal rat cardiomyocyte adherens junctions [J]. Int J Biochem Cell Bio, 2009,41 (7) : 1536-1546.
  • 8Coulouam Y,Lihrmann I,Jegou S,et al.Cloning of cDNA encoding the urotensinⅡprecursor in frog and human reveals intense expression of the urotensin Ⅱ gene in motoneurons ofthe spinal cord[J].Prec Natl Acad Sci USA,1998,95(26):15803.
  • 9Heller J,Schepke M,NeefM,et al.J Hepatol,2002,37(6):767.
  • 10Kemp W,Krum H,Colman J,et al.Urotensin Ⅱ:a novel vasoactive mediator linked to chronic liver disease and portal hypertension[J].Liver Int,2007,27:1232.

引证文献4

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部